Prevention
Health And Interception

Therapeutics

Aiming to Prevent Lung Cancer and Its Recurrence

Get in Touch
PHAIT_logo_symbol_only_white_background
PHAIT, Inc

Clinical Stage Pharmaceutical Company in Seattle

PHAIT, Inc. is a clinical-stage private pharmaceutical company in Seattle. We aim to prevent lung cancer and its recurrence, the world’s #1 cancer killer.

PHAIT.org (Predictive Health Analytics Institute) is a 501(c)(3) that serves as the non-profit complement to PHAIT.com for the purpose of research, clinical studies, and education for cancer prevention that utilizes interventional therapies.

Iloprost

Iloprost is an anti-tumorigenic and anti-inflammatory prostacyclin derivative. It targets patients at risk for lung cancer, a significantly larger market than patients who already have lung cancer. 

PHAIT, Inc.

Well-tolerated

For decades, Iloprost has been used worldwide in a wide range of treatments.

  • Peripheral Occlusion Disease (Intravenous Application)
  • Raynaud’s Disease (Intravenous Application)
  • Pulmonary Arterial Hypertension—PAH (Inhaled Application)
PHAIT, Inc

Demonstrated Effectiveness

Iloprost in the oral form has been successfully used in clinical studies supported by the National Cancer Institute and University of Colorado research for the purpose of chemoprevention of lung cancer. Due to the necessity to maintain high and constant systemic levels of the medication, only oral Iloprost demonstrated effectiveness to reduce dysplasia that can lead to lung cancer. 

Clinical Success

  • Decades of Usage in the Treatment of PAH Show That the Medication is Well Tolerated.
  • Oral Ilopost Was Shown to Reduce Bronchial Dysplasia in a Successful and Published Phase II Clinical Study
  • U. Colorado Led, Multicenter, Randomized, Double-blind, Placebo-controlled.
  • Dysplasia Index (DI) Declined >50% After 6 Months of Oral Iloprost Treatment.
  • Published Results (Keith RL. Cancer Prev Res (Phila). 2011;4(6):793-802).
  • Clinical studies planned for high-risk patient populations for the chemoprevention of lung cancer and its recurrence.

Market Exclusivity

  • Worldwide Exclusive Licenses
  • Method-of-Treatment Patents

Our Inspiration

PHAIT (pronounced "fate") stands for Prevention Health And Interception Therapeutics. Our name is inspired by the legend of the three Fates of Greek mythology. The three Fates or Goddesses determine the length of a person's life by spinning, measuring, and cutting the thread of life. PHAIT aspires to extend the life of individuals by prevention of disease. 

If you would like to read about the legend,

Click Here

Photo Credit